SPECIAL NOTICE
A -- Treating Hereditary Rare Diseases With In Vivo Precision Genetic Medicines (THRIVE)
- Notice Date
- 9/25/2025 6:02:42 AM
- Notice Type
- Special Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H) Washington DC 20005 USA
- ZIP Code
- 20005
- Solicitation Number
- ARPA-H-SN-25-131
- Response Due
- 9/30/2025 8:59:00 PM
- Archive Date
- 10/15/2025
- Point of Contact
- THRIVE Program
- E-Mail Address
-
THRIVE@arpa-h.gov
(THRIVE@arpa-h.gov)
- Small Business Set-Aside
- NONE No Set aside used
- Description
- This Special Notice (SN) is intended to alert the scientific community to a newly approved ARPA-H Program and notify potential proposers of an associated Proposers� Day (PD). Under the cognizance of HSF, ARPA-H is publishing an Innovative Solutions Opening (ISO) for the Treating Hereditary Rare diseases with In Vivo precision genetic mEdicines (THRIVE) program no later than September 25, 2025, please monitor SAM.gov for updates (ARPA-H-SOL-25-122). For additional PD details and registration information see the attached special notice (ARPA-H-SN-25-131). For more information about the THRIVE program visit: https://arpa-h.gov/explore-funding/programs/thrive
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/158c111f6a0d4952b97419c6dccc068c/view)
- Place of Performance
- Address: Washington, DC 20005, USA
- Zip Code: 20005
- Country: USA
- Zip Code: 20005
- Record
- SN07604250-F 20250927/250925230045 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |